SBUX Stock Forecast: Evercore vs Wolfe on the Margin Recovery

North America same-store sales growth improved 13 percentage points across six consecutive quarters, yet Wall Street’s EPS forecasts for Starbucks in fiscal 2028 spread across a $0.35-per-share gap depending on which analyst firm is doing the modelling. The quarterly beat matters. The divergence matters more.

Starbucks reported Q2 FY2026 results on 28 April 2026, delivering revenue up 9% to $9.5 billion, adjusted EPS of $0.50 (beating consensus), and global comparable sales growth of 6.2%. Management simultaneously raised full-year comparable sales guidance to above 5% (from above 3%) and lifted the EPS guidance range to $2.25-$2.45 from $2.15-$2.40. Shares jumped approximately 6% on the news.

Both Evercore and Wolfe Research have since revised their multi-year estimates, arriving at meaningfully different conclusions about the pace of margin recovery through fiscal 2028. What follows moves past the headline stock move to examine what is actually being priced in, where the two forecasts diverge, which catalysts will determine who is right, and what that framework means for investors weighing SBUX near $98.67.

Why the Q2 beat matters more than the stock move suggests

A 6% post-earnings pop looks like a strong quarter rewarded. It is. But the more significant signal sits beneath the single-quarter result.

Revenue of $9.5 billion (up 9%), global comparable sales of $6.2%, and adjusted EPS of $0.50 ahead of estimates are the surface metrics. The trajectory underneath them is what shifted analyst models:

The Starbucks Q2 FY2026 earnings release confirmed consolidated net revenues of $9.5 billion, global comparable store sales growth of 6.2%, and the simultaneous guidance raise across both comparable sales and EPS ranges, providing the primary-source financial disclosures that underpinned the subsequent analyst revisions.

• Revenue: Up 9% to $9.5 billion in Q2 FY2026
• Global comparable sales growth: 6.2%
• Adjusted EPS: $0.50, beating analyst estimates
• Full-year comparable sales guidance: Raised to above 5% (from above 3%)
• Full-year EPS guidance: Raised to $2.25-$2.45 (from $2.15-$2.40)

The credibility marker analysts pointed to was not the headline beat but the composition of North America growth. Transaction growth, rather than ticket size increases, drove the improvement. That distinction matters because traffic-driven comparable sales carry higher repeat probability than price-driven gains.

North America comparable store sales of 7.1% were powered by transaction volume growth of 4.4%, the strongest transaction growth in three years and the second consecutive quarter of positive traffic, a sequencing that makes the recovery harder to dismiss as a single-period anomaly.

Evercore noted that North America same-store sales improved 13 percentage points across the six most recent quarters, a trajectory that has become statistically difficult to dismiss as a one-off recovery.

The guidance raise carries more analytical weight than the quarter itself. When management lifts both comparable sales and EPS ranges simultaneously, the signal is confidence in sustainability, not simply a reflection of a single strong period. For investors evaluating SBUX at current levels, the distinction between a one-quarter bounce and a multi-quarter inflection is the foundational analytical step.

The margin mechanics that will make or break the multi-year thesis

Top-line recovery is confirmed. The harder question is how much of that revenue growth converts into earnings growth, and when. The bull case rests on a sequence of interlocking margin conditions, each with its own timing risk.

From labour headwind to margin tailwind

The first condition is the simplest mechanically but the most frequently misunderstood. Starbucks invested heavily in labour, staffing levels, and wages through FY2025 and into FY2026. Those costs compressed margins in the periods they were incurred. Once those elevated-cost quarters become the prior-year comparison base, FY2027 margins benefit mechanically from lapping the reinvestment.

This is a timing dynamic, not a permanent cost reduction. The labour costs remain in the cost structure. What changes is the year-over-year comparison, making margin expansion appear even if absolute costs hold steady.

Evercore estimates that North America incremental margins ran at approximately negative 7% in FY2026. The firm projects those same incremental margins will exceed 50% in FY2027 as the labour lapping effect, moderation in coffee cost inflation, and productivity savings accumulate simultaneously.

Pacing the path to $2 billion in productivity gains

The second condition is the accumulation of productivity savings, which Evercore expects to reach a cumulative $2 billion by FY2028. The operational levers include technology deployment, supply chain optimisation, and store-level labour efficiency.

The cumulative framing is worth noting. A $2 billion total by FY2028 does not mean $2 billion per year; it means annual contributions that are smaller individually and back-loaded toward the later fiscal years.

The FY2026-to-FY2027 incremental margin inflection is the single most consequential number in the multi-year thesis. If it arrives on schedule, the EPS step-up follows. If it stalls, the entire forward earnings trajectory compresses.

Two firms, two trajectories: mapping the Evercore-Wolfe EPS divergence

The numbers tell the story before the analysis does.

In FY2026, the gap is a modest $0.08. By FY2028, it widens to $0.35. Both firms revised estimates upward following Q2, which is the consensus signal: the direction of the recovery is not in dispute. The divergence is about pace and magnitude.

The specific driver of the gap is margin recovery assumptions. Evercore’s model embeds the 50%-plus incremental margin projection for FY2027 and a steeper productivity savings ramp. Wolfe Research models a more conservative flow-through, implying that labour cost lapping and productivity savings accumulate more gradually than Evercore assumes.

The single most consequential assumption separating the two forecasts is Evercore’s projection that North America incremental margins will exceed 50% in FY2027, a figure that implies the vast majority of top-line growth in that year drops directly to the bottom line.

Evercore maintains an Outperform rating with a price target of $115 (raised from $110). For investors building a position thesis, knowing which margin assumption to test is more useful than averaging the two forecasts. The $0.35 FY2028 gap implies meaningfully different fair value outcomes at any given price-to-earnings multiple.

The catalysts that will separate the optimists from the realists

The backward-looking data is settled. The forward-looking question is which observable events over the next 12-18 months will tell investors whether the Evercore or Wolfe scenario is unfolding. Three catalysts carry the most diagnostic weight:

1. Loyalty programme restructuring (completed March 2026): Wolfe Research described initial indications as promising. The real test is whether restructured programme mechanics drive higher visit frequency or average ticket among lapsed members. Metric to watch: active loyalty membership and redemption rates in Q3 and Q4 earnings supplements.

McKinsey research on loyalty program mechanics shows that points-based currencies and restructured redemption tiers can measurably increase visit frequency and customer lifetime value when programme changes successfully re-engage lapsed members rather than simply reshuffling existing spend, which is precisely the distinction Wolfe Research flagged as the key variable in assessing Starbucks’ March 2026 loyalty restructuring.

1. Energy Refresher product launch (April 2026): Wolfe noted performance in line with or ahead of expectations. New product contribution at scale can accelerate comparable sales without proportional cost increases. Metric to watch: management commentary on product-level comparable sales mix in the next two quarters.
2. North America momentum beyond Q2: Traffic-driven comparable sales growth was confirmed continuing into April 2026 beyond the reported quarter. Metric to watch: whether Q3 comparable sales sustain the 6%+ trajectory or decelerate as the prior-year comparison base becomes more demanding.

International markets: the unpriced optionality

Analyst commentary on Q2 focused heavily on North America strength. International challenges were acknowledged but did not overshadow the domestic recovery narrative. Neither Evercore nor Wolfe appears to be embedding a meaningful international recovery in their base-case estimates.

That creates a form of optionality. If stabilisation occurs in markets such as China, it represents upside to both firms’ models rather than a required input. Investors should treat international recovery as a potential catalyst rather than a base-case assumption.

What Starbucks’ valuation looks like at current levels

At approximately $98.67 (intraday on 29 April 2026), Starbucks is trading near the median consensus target of approximately $100. Year-to-date gains of approximately 16.27% and a price roughly 6% below the 52-week high of $104.82 suggest the initial turnaround narrative has been substantially priced in.

Analyst ratings on Starbucks split nearly evenly: 17 Buy, 18 Hold, and 4 Sell across approximately 35 covering analysts, reflecting a market that recognises the turnaround direction but remains divided on the magnitude of remaining upside.

The 52-week range of $75.50 to $104.82 provides context. The stock has recovered 30.7% from its low. At $98.67, the consensus view implies limited near-term upside, while the bull-case targets from Evercore and Stifel ($115) and Bank of America ($130) imply 16-32% upside, contingent on the FY2027-FY2028 margin inflection arriving as modelled.

The next leg of upside, if it materialises, is an earnings-delivery story, not a narrative re-rating story.

The margin inflection window is narrow and the timeline is the whole trade

The analytical conclusion from the preceding sections is straightforward in direction and uncertain in magnitude. The top-line recovery is confirmed. The margin recovery is still in transit. The FY2027 incremental margin inflection is the single event that will validate or challenge the bull case.

Investors who believe the margin mechanics will arrive on Evercore’s schedule (FY2028 EPS of $4.00) are buying a FY2027-FY2028 story at FY2026 prices. Those who align with Wolfe Research’s more conservative view (FY2028 EPS of $3.65) are pricing in a longer runway before full flow-through. The $0.35 gap between those endpoints defines the range of outcomes.

Three metrics over the next two to three quarters will provide the clearest signal:

The operating margin expansion required to close the gap between the current 9.4% operating margin and the 12.8% normalised assumption embedded in the $115 price target is 340 basis points, a figure that quantifies precisely how much execution headroom separates the bull case from current reality.

• North America incremental margins in Q3 and Q4 FY2026: The progression from negative 7% toward the projected 50%-plus inflection is the lead indicator of whether Evercore’s timeline holds.
• Productivity savings disclosures on earnings calls: Management commentary on the pace of the cumulative $2 billion target will indicate whether savings are front-loaded or back-loaded relative to Evercore’s model.
• Loyalty programme engagement data: Membership and redemption metrics will reveal whether the March 2026 restructuring is driving incremental traffic or simply reshuffling existing customers.

The guidance midpoint for FY2026 sits at $2.35. That is the near-term anchor. How the company tracks against it over the next two quarters will tell investors whether the margin inflection is arriving, or whether the consensus was right to price the stock at the median target.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.

—